Skip to Main Content

Paper Details

Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease.
Nat Commun
6
2022
CpGs, DNA, DNA methylation, Type 1 diabetes, blood, diabetic kidney, diabetic kidney disease, genome, kidney failure, type 1 diabetes
Author NameAffiliation
Viji NairUniversity of Michigan School of Medicine ann arbor
Damian FerminUniversity of Michigan School of Medicine ann arbor
Robert G NelsonNational Institute of Diabetes and Digestive and Kidney Diseases
Joanne B ColeBroad Institute
Joanne B ColeDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital
Rany M SalemHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego
Matthias KretzlerUniversity of Michigan ann arbor
Matthias KretzlerUniversity of Michigan ann arbor
Joel N HirschhornBroad Institute
Joel N HirschhornHarvard Medical School
Joel N HirschhornBoston Children's Hospital
Joel N HirschhornBroad Institute
Joel N HirschhornBoston Children's Hospital
Joel N HirschhornHarvard Medical School
Jose C FlorezBroad Institute
Jose C FlorezHarvard Medical School
Jose C FlorezDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital
Carol ForsblomFolkhalsan Institute of Genetics, Folkhalsan Research Center
Carol ForsblomUniversity of Helsinki and Helsinki University Hospital
Carol ForsblomResearch Program for Clinical and Molecular Metabolism, University of Helsinki
Per-Henrik GroopFolkhalsan Institute of Genetics, Folkhalsan Research Center
Per-Henrik GroopUniversity of Helsinki and Helsinki University Hospital
Per-Henrik GroopResearch Program for Clinical and Molecular Metabolism, University of Helsinki
Per-Henrik GroopCentral Clinical School, Monash University
  • 1 - 24

Datasets